NCT06661291 Pip Care to Improve Surgical Patient Outcomes
| NCT ID | NCT06661291 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pittsburgh |
| Condition | Abdominal Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,300 participants |
| Start Date | 2025-10-13 |
| Primary Completion | 2028-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,300 participants in total. It began in 2025-10-13 with a primary completion date of 2028-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pip Care is developing a personalized, interactive surgical journey platform with a live health coach that works directly with health systems to optimize the perioperative care process. Our Health Insurance Portability and Accountability Act (HIPAA)-compliant platform, Pip, can be integrated into any electronic medical record (EMR), thus alleviating the administrative burden by making operational workflows more efficient. The PIP empowers patients and their families to be more involved in their care by breaking down a patient's healthcare plan into definable, easy-to-understand, and easy-to-complete tasks. Additionally, a health coach completes a health intake to create a personalized perioperative care plan, meets regularly with the patient to encourage goal accomplishment, and facilitates care coordination. This project has 2 phases; Phase I is to assess usability of the Pip Care platform in surgical patients, Phase II is a RCT (Randomized Controlled Trial) to assess surgical clinical outcomes while using Pip compared to standard of care.
Eligibility Criteria
Inclusion Criteria: 1. Adult patient ≥18 years old 2. Planned elective, inpatient surgery between 2 to 8 weeks following enrollment in Pip within the following surgical specialties: complex abdominal surgery (general surgery, colorectal surgery, surgical oncology), gynecologic oncology, thoracic surgery, spine surgery, and orthopedic joint surgery 3. Daily access to a smartphone or tablet. Exclusion Criteria: 1. Unable to speak English 2. Unable to use a smartphone or tablet independently or with daily assistance. 3. Currently pregnant (assessed via standard-of-care pre-operative workup)
Contact & Investigator
Jennifer Holder-Murray, MD
PRINCIPAL INVESTIGATOR
University of Pittsburgh, UPMC
Frequently Asked Questions
Who can join the NCT06661291 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Abdominal Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06661291 currently recruiting?
Yes, NCT06661291 is actively recruiting participants. Contact the research team at riedmannca@upmc.edu for enrollment information.
Where is the NCT06661291 trial being conducted?
This trial is being conducted at New Castle, United States, Pittsburgh, United States, Pittsburgh, United States, Pittsburgh, United States and 4 additional locations.
Who is sponsoring the NCT06661291 clinical trial?
NCT06661291 is sponsored by University of Pittsburgh. The principal investigator is Jennifer Holder-Murray, MD at University of Pittsburgh, UPMC. The trial plans to enroll 1,300 participants.